A survey of psychotropic drug prescriptions in an oncology population.
about
The vital link between chronic disease and depressive disorders.Use of psychotropic medications by US cancer survivors.The relationship between fatigue and sleep in cancer patients: a review.Sleep dysfunction in patients with cancer.Sleep aid use during and following breast cancer adjuvant chemotherapy.Sleep Disturbances in Cancer.Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.Anxiety in terminally ill cancer patients.Inadequate symptom control in advanced cancer patients across Europe.Psychiatric comorbidity among terminally ill patients in general practice in the Netherlands: a comparison between patients with cancer and heart failure.Insomnia and its treatment in women with breast cancer.Psychosomatic Aspects of Gynecologic Oncology: Present Status and Future DirectionsRadiation Therapy and Psychological Distress in Gynecologic Oncology Patients: Outcomes and Recommendations for Enhancing Adjustment.Short- and long-term use of medication for psychological distress after the diagnosis of cancer.Psychopharmacology in psycho-oncology.Prevalence and initial prescription of psychotropics in patients with common cancers in Japan, based on a nationwide health insurance claims database.A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients.Acupuncture for Managing Cancer-Related Insomnia: A Systematic Review of Randomized Clinical Trials.Contributions of benzodiazepines to cancer therapy.The emergency treatment of the depressed patient with physical illness.Polypharmacy in psychiatry: update and future trends.Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands.Psychotropic drug dispensing in people with and without cancer in France.Utilization of hypnotic medication in the context of cancer: predictors and frequency of use.Psychiatric symptoms in cancer patients. Is the cause organic or psychologic?Consultation-liaison psychiatry in an Australian oncology unit.
P2860
Q25255770-DC87F4C7-2965-4D46-AD92-6CF2A6FB43F0Q33836919-45BFD7E8-2A92-4315-A6D6-3BDEB07DB71DQ34184090-465A01D8-E20C-41AA-A040-DE8712B8031CQ34184105-D6B5F9CF-8FCA-4BD2-ACCE-20C6718FD595Q34453760-700CAE8A-A029-41CA-AB85-C22AC0013767Q34492604-F896AE9E-F342-4657-9575-C31006E5BDD3Q35143365-2A760BD1-6B65-43C5-B8BC-FF6610D9B3B3Q35230737-C3EDF71E-109F-48D1-B14F-2606DF61442FQ35475449-4AB865DC-CCD9-4C9F-8B33-EB15B818DE97Q36485901-718733A3-3E91-4DFB-8351-12ED04456D8FQ36590211-4600EF31-979F-4284-99F4-7695E4F4253DQ37390744-200425CE-84EC-4B57-B4D2-D21720A3A843Q37390784-EA931E93-60E4-4A80-9487-AF17746706C7Q37607289-3427D0F3-CD9D-46AE-9E25-3A6BFE5C749DQ38129301-61AC0493-0EB4-4D3D-9689-457F5C826810Q38657403-8CF046FC-75C0-47D0-9358-34D394687BABQ38699335-056C8D3B-097B-41E3-8304-EAFA50B272E9Q38929300-450A0FCF-E3BE-4FE5-85ED-34D6B76D932FQ39467653-4D52209A-B0A0-4F33-B6F7-EBE8C1158824Q39655588-9CE871AB-F06E-4D46-87ED-2034BCD3854BQ39754245-033801E6-5544-4828-8983-D9B01482B0F3Q44222148-E73D4E9D-8477-4558-B9FC-4E00B40B4580Q48099427-44E843CC-A13E-489C-A812-2F288D376ACDQ48299559-607D704A-EB3C-43D3-9051-7517F85AB93FQ48783760-504FEE79-27E3-428C-B6A2-CA9E47B3ACA7Q51004765-CA550879-5AB2-4C3E-BC88-46D164E7EF84
P2860
A survey of psychotropic drug prescriptions in an oncology population.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
A survey of psychotropic drug prescriptions in an oncology population.
@en
A survey of psychotropic drug prescriptions in an oncology population.
@nl
type
label
A survey of psychotropic drug prescriptions in an oncology population.
@en
A survey of psychotropic drug prescriptions in an oncology population.
@nl
prefLabel
A survey of psychotropic drug prescriptions in an oncology population.
@en
A survey of psychotropic drug prescriptions in an oncology population.
@nl
P2093
P1433
P1476
A survey of psychotropic drug prescriptions in an oncology population.
@en
P2093
Derogatis LR
Feldstein M
Melisaratos N
Murawski B
P304
P356
10.1002/1097-0142(197911)44:5<1919::AID-CNCR2820440555>3.0.CO;2-T
P407
P577
1979-11-01T00:00:00Z